Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net income (loss)	$ 795,259	$ (2,974,106)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	38,817	34,269
Net (gains) losses realized on the sale of securities and net credit losses recognized in operations	103,325	15,288
Unrealized (gains) losses on equity securities	(311,127)	1,704,079
Change in fair value of embedded derivative	(425,122)	1,090,435
(Accretion) amortization of investment securities, net	(236,651)	122,226
Deferred acquisition costs capitalized	(394,449)	(358,384)
Deferred acquisition costs amortized	1,059,975	900,532
Value of business acquired amortized	69,315	69,315
Interest credited on deposit type contracts	1,328,688	1,221,761
(Increase) decrease in operating assets:
Change in funds withheld	0	(1,672,678)
Investment income due and accrued	(525,563)	84,483
Reinsurance related assets	(772,248)	(259,236)
Other assets	(244,699)	(689,873)
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	3,414,010	3,408,118
Dividend accumulation	(3,513)	2,458
Advance premiums	(16,484)	22,168
Other liabilities	(1,532)	1,101,026
Accounts payable and accrued expenses	2,248,135	(481,892)
Net cash provided by operating activities	6,126,136	3,339,989
Cash Flows from investing activities:
Purchase of fixed income investments	(6,022,114)	(3,568,922)
Purchase of equity investments	(477,673)	(1,196,212)
Purchase of mortgage investments	(4,150,647)	(4,020,252)
Purchase of other invested assets	(810,545)	0
Proceeds from fixed income sales and repayments	3,528,290	1,120,625
Proceeds from equity sales	1,106,288	422,909
Proceeds from mortgage repayments	5,249,848	3,566,093
Proceeds from other invested assets	547,952	0
Increase in policy loans	9,615	138,639
Purchase of property, equipment and software	(209,659)	(56,401)
Net cash used in investing activities	(1,228,645)	(3,593,521)
Cash Flows from financing activities:
Receipts on deposit-type contracts	3,544,001	4,431,894
Withdrawals on deposit-type contracts	(6,389,402)	(1,752,421)
Repayment of FHLB advance	0	(1,000,000)
Proceeds received from issuance of common stock, net of costs of issuance	9,232	6,973
Net cash provided by (used in) financing activities	(2,836,169)	1,686,446
Net increase in cash and cash equivalents	2,061,322	1,432,914
Cash and Cash Equivalents:
Beginning	4,091,507	7,955,348
Ending	6,152,829	9,388,262
Supplemental Disclosure of Non-Cash Information
Funds withheld assumed deposits on deposit-type contracts	0	639,610
Funds withheld assumed withdrawals on deposit-type contracts	0	(915,520)
Commissions and expense allowances deducted from funds withheld	$ 0	$ (908,074)